AU2001277599A1 - Essential oil combination and therapeutic uses thereof - Google Patents

Essential oil combination and therapeutic uses thereof

Info

Publication number
AU2001277599A1
AU2001277599A1 AU2001277599A AU7759901A AU2001277599A1 AU 2001277599 A1 AU2001277599 A1 AU 2001277599A1 AU 2001277599 A AU2001277599 A AU 2001277599A AU 7759901 A AU7759901 A AU 7759901A AU 2001277599 A1 AU2001277599 A1 AU 2001277599A1
Authority
AU
Australia
Prior art keywords
therapeutic uses
essential oil
oil combination
combination
essential oils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277599A
Inventor
Anne Marie Pierrette Giraud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001277599A1 publication Critical patent/AU2001277599A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention concerns the combination of at least two essential oils selected among Helichrysum Italicum ssp Serotinum, Ledum Groenlandicum and Ravensara Aromatica essential oils, for simultaneous, separate or prolonged use, and the therapeutic uses thereof.
AU2001277599A 2000-07-20 2001-07-17 Essential oil combination and therapeutic uses thereof Abandoned AU2001277599A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0009515 2000-07-20
FR0009515A FR2811899B1 (en) 2000-07-20 2000-07-20 ASSOCIATION OF ESSENTIAL OILS AND THERAPEUTIC APPLICATIONS
PCT/FR2001/002325 WO2002007744A1 (en) 2000-07-20 2001-07-17 Essential oil combination and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2001277599A1 true AU2001277599A1 (en) 2002-02-05

Family

ID=8852728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277599A Abandoned AU2001277599A1 (en) 2000-07-20 2001-07-17 Essential oil combination and therapeutic uses thereof

Country Status (6)

Country Link
EP (1) EP1301194B1 (en)
AT (1) ATE462439T1 (en)
AU (1) AU2001277599A1 (en)
DE (1) DE60141694D1 (en)
FR (1) FR2811899B1 (en)
WO (1) WO2002007744A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7571511B2 (en) 2002-01-03 2009-08-11 Irobot Corporation Autonomous floor-cleaning robot
CA2342403A1 (en) * 2001-03-28 2002-09-28 Jean Legault Sesquiterpene derivatives as anticancer agents
CA2356438A1 (en) * 2001-09-05 2003-03-05 Andre Pichette Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers
DE10335634B4 (en) * 2003-08-01 2007-06-06 Dr. André Rieks, Labor für Enzymtechnologie GmbH Use of perilla-, geranium- and citronellic acid as well as selected derivatives for preservation, for the treatment of acne, dandruff or dematomycoses as well as for combating body odor-causing microorganisms
GB0326518D0 (en) * 2003-11-13 2003-12-17 Compton Developments Ltd Anti-cancer compounds
WO2006087039A1 (en) * 2005-02-17 2006-08-24 Propharex Sa Broad spectrum anti viral herbal composition
ITTO20050869A1 (en) * 2005-12-14 2007-06-15 Massimelli Daniele Maria ANTIVIRAL, VIRUCID AND IMMUNOMODULATING COMPOSITION BASED ON OFFICINAL PLANTS AND ITS METHOD FOR THE TREATMENT OF DISEASES OF VIRAL ORIGIN, IN PARTICULAR OF HIV INFECTION.
ITMI20060063A1 (en) 2006-01-17 2007-07-18 Aboca S P A NON-HYDRO-SOLUBLE HELICRIST EXTRACT PROCEDURE FOR ITS PREPARATION AND ITS USES
US9056063B2 (en) 2012-03-13 2015-06-16 James E. Hanson Natural sunscreen composition
FR3042709B1 (en) * 2015-10-21 2020-10-23 Laboratoires De Biologie Vegetale Yves Rocher COSMETIC USE OF A LEDUM GREENLANDICUM EXTRACT
DE202015106125U1 (en) * 2015-10-23 2016-10-27 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Monoterpenhaltige composition for the treatment of cancer and / or cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2709964B1 (en) 1993-09-14 1995-11-17 Dupont Paul Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes.
US5785972A (en) 1997-01-10 1998-07-28 Tyler; Kathleen A. Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application

Also Published As

Publication number Publication date
FR2811899A1 (en) 2002-01-25
ATE462439T1 (en) 2010-04-15
EP1301194B1 (en) 2010-03-31
FR2811899B1 (en) 2003-02-07
DE60141694D1 (en) 2010-05-12
WO2002007744A1 (en) 2002-01-31
EP1301194A1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU3276802A (en) Background of the invention
WO2001070275A3 (en) Polyglutamic acid-camptothecin conjugates and methods of preparation
PT960107E (en) 6-TIO-SUBSTITUTED PACLITAXEL COMPOUNDS
WO2002074293A3 (en) Methods for restoring cognitive function following systemic stress
MXPA03007088A (en) Lubricant composition.
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
AU2002336374A1 (en) Line selected f¿2? two chamber laser system
AU2001277599A1 (en) Essential oil combination and therapeutic uses thereof
MY130718A (en) Antitumor compounds and methods
IL152411A0 (en) Zolpidem hemitartrate
GB0107383D0 (en) Lipid profile modulation
HK1049432A1 (en) Transparent high oil loaded microemulsions
AU2001279579A1 (en) Caster
AU2002346676A1 (en) Traction fluids
WO2002060483A3 (en) Perylenequinones for use as photosensitizers and sonosensitizers
AU6279500A (en) Epothilone compositions
YU3400A (en) New salts with beneficial organoleptic properties
IL139144A0 (en) Mycobacterial inhibitors
MXPA05013625A (en) Combinations of vasoprotective agents and formulations containing them.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
HK1056828A1 (en) Treatment of burns.
WO2001010424A3 (en) Reducing cholesterol oxides using n-3-pufa and vitamin e
AU2857401A (en) Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
WO2003018763A3 (en) Modulation of appl expression
WO2001049298A3 (en) Novel therapeutic use of enoxaparin